ahlam1399
03-29-2016, 12:50 PM
BRIEF-Japan approves GlaxoSmithkline?s asthma drug Nucala
* Receives marketing authorisation for nucala (mepolizumab) in Japan
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e91e5e8/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=BtAyD9NP91s:4U84a8ImS1E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BtAyD9NP91s:4U84a8ImS1E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=BtAyD9NP91s:4U84a8ImS1E:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BtAyD9NP91s:4U84a8ImS1E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=BtAyD9NP91s:4U84a8ImS1E:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/BtAyD9NP91s
* Receives marketing authorisation for nucala (mepolizumab) in Japan
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e91e5e8/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=BtAyD9NP91s:4U84a8ImS1E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BtAyD9NP91s:4U84a8ImS1E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=BtAyD9NP91s:4U84a8ImS1E:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BtAyD9NP91s:4U84a8ImS1E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=BtAyD9NP91s:4U84a8ImS1E:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/BtAyD9NP91s